Simply enter your keyword and we will help you find what you need.

What are you looking for?

  • No products in the cart.
Image Alt

India's healthcare sector continues to grow strongly, driven by the increasing prevalence of lifestyle diseases, improving middle class purchasing power and improving technologies and practices. The diagnostics industry in particular has undergone enormous changes in the last 2-3 decades. With increasing PE (Private Equity) - investments, intensified competition, rapid technical progress and improved quality regulations - this segment of the healthcare industry is prepared for further growth. Many CEOs and business leaders see new opportunities in the Indian diagnostics market, such as the growing demand for diagnostic services, expanded access to such services, increased insurance penetration and more. Experts expect the industry to grow from a compound annual growth rate (CAGR) of around 16 percent in fiscal 2020 to around $802

The Middle Kingdom has managed to do what other emerging markets are still far from doing: In just a few decades, the country's increasingly flourishing economy has almost conquered the markets for itself, for Europe and the USA are in no way inferior in terms of innovation, quite the opposite: Hotspots such as Dream Town in Hangzhou, Shenzhen or Beijing could soon seriously set Silicon Valley back as a pioneer. Their advantage: Ubiquitous information and communication technologies, deeply integrated into the everyday lives of their users, whereby among the nearly 1.5 billion people in China there are currently around 720 million Internet users, according to forecasts even 300 million more in the coming years. In contrast to Western nations, digitization is

Once closed for tactical reasons, entrepreneurial partnerships are now increasingly emerging due to digitalization and globalization and the interdependencies they create. The objectives may still be the same: Upgrading intentions, competitive advantages, entry acquisition or synergy exploitation, to name a few. Here, China, today more than ever, holds immense potential for achieving its own goals within the Asia-Pacific region. With growing domestic consumer demand due to increased prosperity, China has opened the market to small and medium-sized enterprises. The framework conditions for this can be found in the Small and Medium-Sized Enterprises (SME) Policy Index [1]. China's market is considered an exception: difficult to access and internally complex. Its enormous and above all sustainable growth and factors such as China's investment in

The pitch of the startup scene is like the casting of the fashion industry. Only a few seconds to minutes decide about success or failure for lucrative jobs or lucrative capital. During the seed phase, startups advertise for their own (realistic) vision, whether alone or in direct competition on startup weekends or pitch events (live pitch) or crowdfunding platforms, such as seedmatch (digital pitch), in order to attract investors. Without external support, this vision usually does not last long. In the LifeScience sector, in addition to the DxPx conference, the T4M Start-up World trade fair, the MedTech Summit congress or the bionection Partnering Conference are also possible options. While DxPx puts the field of diagnostics in the foreground and focuses

The growth of the LifeScience sector is expected to be driven by rising demands from an aging population and the prevalence of chronic and communicable diseases. The Chinese market in particular, with its huge population, which has been slowed down for a short time by the one-child policy, but has slipped into a problem of providing care for the elderly, is predestined for the diagnostics and RUO industry. And as is often the case, the right timing is crucial in life, but also in a growing market – and the Chinese LifeScience market can be labeled as such. Opportunities exist for both multinational and local pharmaceutical companies through government support for the sector (by increasing health care accessibility, improving quality and controlling

In one of the fastest growing economies in the world, China, fundraising has always been an important issue for local and foreign companies to expand their operations. In contrast to the West, however, this is a much more challenging undertaking in the Middle Kingdom and requires a lot of attention. To make fundraising successful, it is necessary to build a solid base with all relevant social classes, but cultural barriers make it difficult. The focus is therefore on the relationship with all stakeholders - those who show interest, empathy and care are successful. General Conditions Nowadays, online presence is essential for every company. If you are planning to enter the Chinese market, one of the most important points of your marketing strategy

Everyone knows the story of David and Goliath - if not the actual details about who each of the two protagonists of the most famous disparity in history was, or why they faced each other at all, then surely the result. Little David beats the seemingly invincible giant Goliath. Over the years, the story has inspired many negotiators to "get started". It's also important for startups, either digital health startups or diagnostic startups, to learn how to act confidently in negotiations, even when you're the smaller company, David, and you're facing a bigger LifeScience company. The following lessons can be learned from David in his fight against Goliath and can also be applied to his own "fights". First, and foremost, he had